The application of immunostaining for PD-L1 as a means to ascertain the presence of immune evasion mechanisms in tumor cells enables the classification of EBV+DLBCL and B cell lymphoproliferative disorder into three distinct categories: immunodeficient, immune evasion, and immunodeficient + immune evasion. This evidence concerns the gene CD274 and neoplasm.